메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Park, Jee-Yeon (Department of Pharmacology, Institute for Basic Medical Science[IBMS], School of Medicine, Kyung Hee University) Seo, Young-R. (Department of Pharmacology, Institute for Basic Medical Science[IBMS], School of Medicine, Kyung Hee University)
저널정보
대한독성유전단백체학회 Molecular & cellular toxicology Molecular & cellular toxicology 제6권 제1호
발행연도
2010.1
수록면
51 - 56 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
The nuclear erythroid factor 2-related factor 2 (Nrf2) is widely known as an important redox factor to protect cells from oxidative stress. However, recently it is known that Nrf2 in cancer cells provides advantages for cell viability from the exposure to anticancer drugs. Mitomycin C (MMC) is an anticancer drug for treatment of several types of cancers including colon and breast cancers. It is potent DNA crosslinker. MMC is able to induce ROS as part of its mechanism of action, which exerts detrimental effects to cancer cells. In this study, we investigated the role of Nrf2 in resistance to MMC in human colon cancer cells. Stable Nrf2 shRNA-expressing RKO showed higher sensitivity to MMC exposure than Nrf2 wild type cells. Furthermore, significantly increased apoptosis was associated with high level of oxidative stress and expression of DNA damage sensitive protein, phosphorylated H2AX (gamma-H2AX) in Nrf2 deficient human colon RKO cells. In conclusion, we demonstrated for the first time that Nrf2 enhanced MMC-resistance via inhibition of oxidative stress and DNA damage in human colon cancer cells. Therefore, we suggested that Nrf2 might be potential therapeutic target in the MMC treatment of colon cancer.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0